全文获取类型
收费全文 | 22190篇 |
免费 | 2262篇 |
国内免费 | 860篇 |
专业分类
耳鼻咽喉 | 270篇 |
儿科学 | 255篇 |
妇产科学 | 520篇 |
基础医学 | 2337篇 |
口腔科学 | 419篇 |
临床医学 | 1854篇 |
内科学 | 3039篇 |
皮肤病学 | 175篇 |
神经病学 | 474篇 |
特种医学 | 541篇 |
外国民族医学 | 21篇 |
外科学 | 5853篇 |
综合类 | 3288篇 |
现状与发展 | 4篇 |
预防医学 | 740篇 |
眼科学 | 175篇 |
药学 | 1193篇 |
34篇 | |
中国医学 | 235篇 |
肿瘤学 | 3885篇 |
出版年
2024年 | 36篇 |
2023年 | 566篇 |
2022年 | 844篇 |
2021年 | 1283篇 |
2020年 | 1303篇 |
2019年 | 1141篇 |
2018年 | 1015篇 |
2017年 | 1022篇 |
2016年 | 1215篇 |
2015年 | 1191篇 |
2014年 | 2073篇 |
2013年 | 1732篇 |
2012年 | 1467篇 |
2011年 | 1516篇 |
2010年 | 1144篇 |
2009年 | 1049篇 |
2008年 | 982篇 |
2007年 | 952篇 |
2006年 | 812篇 |
2005年 | 707篇 |
2004年 | 548篇 |
2003年 | 456篇 |
2002年 | 365篇 |
2001年 | 277篇 |
2000年 | 248篇 |
1999年 | 174篇 |
1998年 | 171篇 |
1997年 | 121篇 |
1996年 | 111篇 |
1995年 | 122篇 |
1994年 | 114篇 |
1993年 | 76篇 |
1992年 | 67篇 |
1991年 | 64篇 |
1990年 | 45篇 |
1989年 | 48篇 |
1988年 | 42篇 |
1987年 | 32篇 |
1986年 | 32篇 |
1985年 | 30篇 |
1984年 | 17篇 |
1983年 | 26篇 |
1982年 | 15篇 |
1981年 | 16篇 |
1980年 | 18篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 2篇 |
1975年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
《European journal of surgical oncology》2022,48(5):1062-1067
BackgroundSurgical resection is recommended for patients with resectable acinar cell carcinoma (ACC). The aim of this study was to investigate the clinical characteristics and surgical outcomes of resectable ACC in comparison to pancreatic ductal adenocarcinoma (PDAC).MethodA retrospective analysis was performed on all patients who consecutively underwent radical resection with pathologically confirmed ACC and PDAC from December 2011 to December 2018. Clinicopathologic characteristics and follow-up information were analyzed. A 1:3 propensity score matching (PSM) method was used to minimize the bias between ACC and PDAC.ResultsA total of 26 patients with ACC and 1351 with PDAC were included. Compared to PDAC, ACC tended to be larger (4.5 vs. 3.0 cm; p < 0.001) and more frequently located in the pancreatic body/tail (61.5% vs. 36.6%, p = 0.009), with lower total bilirubin levels, lower neutrophil lymphocyte ratio (NLR) levels and lower carbohydrate antigen 19-9 (CA19-9) levels and carcinoembryonic antigen (CEA) levels. There was no difference in postoperative morbidities in patients with ACC and PDAC. The median OS and RFS were longer in ACC when compared to PDAC (OS: 43.5 mo vs. 19.0 mo, p = 0.004; RFS: 24.5 mo vs. 11.6 mo, p = 0.023). After the 1:3 PSM, ACC remained to be a better histological type for OS (p = 0.024), but had comparable RFS with PDAC (p = 0.164).ConclusionPatients with ACC after radical resection had better OS than that with PDAC. However, ACC is also an aggressive tumor with a similar trend of RFS with PDAC after the matching, necessitating the multidisciplinary treatment for resectable ACC disease. 相似文献
2.
3.
The seventh leading cause of cancer-related death globally, pancreatic ductal adenocarcinoma (PDAC) involves the exocrine pancreas and constitutes greater than 90% of all pancreatic cancers. Surgical resection in combination with systemic chemotherapy with or without radiation remains the mainstay of treatment and the only potentially curative treatment option. While there has been improvement in systemic chemotherapy, long-term survival among patients with PDAC remains poor. Improvement in the understanding of tumorigenesis, genetic mutations, the tumor microenvironment (TME), immunotherapies, as well as targeted therapies continued to drive advances in PDAC treatment. We herein review the TME, genetic landscape, as well as various metabolic pathways associated with PDAC tumorigenesis relative to emerging therapies. 相似文献
4.
《Journal of Cardiovascular Computed Tomography》2022,16(6):483-490
BackgroundInflammation surrounding the coronary arteries can be non-invasively assessed using pericoronary adipose tissue attenuation (PCAT). While PCAT holds promise for further risk stratification of patients with low coronary artery disease (CAD) prevalence, its value in higher risk populations remains unknown.MethodsCORE320 enrolled patients referred for invasive coronary angiography with known or suspected CAD. Coronary computed tomography angiography (CCTA) images were collected for 381 patients for whom clinical outcomes were assessed 5 years after enrollment. Using semi-automated image analysis software, PCAT was obtained and normalized for the right coronary (RCA), left anterior descending (LAD), and left circumflex arteries (LCx). The association between PCAT and major adverse cardiovascular events (MACE) during follow up was assessed using Cox regression models.ResultsThirty-seven patients were excluded due to technical failure. For the remaining 344 patients, median age was 62 (interquartile range, 55–68) with 59% having ≥1 coronary artery stenosis of ≥50% by quantitative coronary angiography. Mean attenuation values for PCAT in RCA, LAD, and LCx were ?74.9, ?74.2, and ?71.2, respectively. Hazard ratios and 95% confidence intervals (CI) for normalized PCAT in the RCA, LAD, and LCx for MACE were 0.96 (CI: 0.75–1.22, p ?= ?0.71), 1.31 (95% CI: 0.96–1.78, p ?= ?0.09), and 0.98 (95% CI: 0.78–1.22, p ?= ?0.84), respectively. For death, stroke, or myocardial infarction only, hazard ratios were 0.68 (0.44–1.07), 0.85 (0.56–1.29), and 0.57 (0.41–0.80), respectively.ConclusionsIn patients referred for invasive coronary angiography with suspected CAD, PCAT did not predict MACE during long term follow up. Further studies are needed to understand the relationship of PCAT with CAD risk. 相似文献
5.
6.
胰腺癌新辅助化疗在临床应用愈加广泛。对于新辅助化疗后病人,腹腔镜胰十二指肠切除术是否安全有效,尚无研究。胰腺癌新辅助化疗后,肿瘤局部纤维结缔组织的炎症会导致缺乏良好组织间隙,解剖分离困难,因此微创手术的难点在于切除过程,而重建相对固定且成熟,很少会受到新辅助化疗的影响。新辅助化疗后,影像学评估肿瘤退缩效果往往不明显,更多的在于对肿瘤标记物等反应肿瘤生物学指标的控制。手术合并血管切除重建的比例相对较高,但得益于3D腹腔镜高清晰度和放大的手术视野,有利受侵犯血管的切除和重建。新辅助化疗后腹腔镜胰十二指肠切除术与开放手术相比,长期生存率是否存在差异,尚需前瞻性、大样本、多中心随机对照临床试验加以验证。 相似文献
7.
8.
9.
10.